Vertex Pharmaceuticals Secures Future Pipeline with $4.9 Billion Alpine Immune Sciences Acquisition
The biotechnology landscape witnessed a significant consolidation in the second quarter of 2024 as Vertex Pharmaceuticals Incorporated finalized its acquisition ...





